NCT00485810 Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT00485498 Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics Status COMPLETED Phase PHASE4
NCT00484302 Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis Status COMPLETED Phase NA
NCT00483964 A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia Status COMPLETED Phase PHASE2
NCT00482430 MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027) Status COMPLETED Phase PHASE2
NCT00481156 Functional Neuroimaging Effects of Cognitive Remediation Training Status COMPLETED Phase PHASE3
NCT00481026 A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression Status COMPLETED Phase NA
NCT00480844 Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone Status UNKNOWN Phase PHASE4
NCT00480571 Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder Status COMPLETED Phase PHASE2
NCT00473434 An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00472862 Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual Status COMPLETED Phase PHASE3
NCT00470106 Improving Basic and Social Cognition in Veterans With Schizophrenia Status COMPLETED Phase NA
NCT00469664 Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia Status UNKNOWN Phase PHASE4
NCT00466323 The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. Status COMPLETED Phase NA
NCT00465920 Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis Status UNKNOWN Phase PHASE2
NCT00463372 Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT00463346 Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism Status COMPLETED Phase PHASE3